Semax Spray10mg
Semax Spray Canada — Nasal Spray
ACTH-Derived Research Peptide
Semax Spray is an intranasal research formulation of the Semax peptide studied for its effects on neurotrophic and cognitive-related signaling pathways in laboratory models. Research commonly examines its interaction with brain-derived regulatory mechanisms, receptor activity, and peptide transport dynamics in controlled experimental settings.
Maximum available quantity reached (1)
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–10) with structural modification to enhance stability in experimental systems. It is developed for controlled laboratory research involving neuropeptide signaling pathways.
In scientific literature, Semax is studied in models examining neuroendocrine signaling frameworks, peptide-mediated receptor interaction systems, and downstream regulatory mechanisms under in vitro and preclinical research conditions.
Third-party tested for purity, identity, quantity.
Semax is a modified ACTH fragment evaluated in research focused on neuropeptide signaling and central nervous system pathway interaction. Experimental studies examine its interaction with receptor-mediated signaling frameworks and peptide regulatory systems within controlled laboratory environments.
Research publications have explored its signaling characteristics and pathway-level interaction models under structured experimental conditions.
Semax was developed through investigations into synthetic derivatives of ACTH fragments designed to modify stability and signaling properties. Research expanded into neuropeptide pathway studies and central signaling system frameworks.
Subsequent publications documented its receptor interaction profile and regulatory signaling behavior in laboratory research models.
Laboratory investigations into Semax have focused on neuropeptide signaling models and receptor-mediated pathway interaction systems. Research frameworks evaluate peptide stability, central signaling dynamics, and downstream regulatory mechanisms under controlled in vitro and preclinical conditions.
0 of the 4 areas below are addressed directly by a paper cited on this page.
No paper is cited on this page for Semax Spray, so nothing supports this line of enquiry specifically. The heading describes where the compound is discussed in this category, not what has been shown about it.
No paper is cited on this page for Semax Spray, so nothing supports this line of enquiry specifically. The heading describes where the compound is discussed in this category, not what has been shown about it.
No paper is cited on this page for Semax Spray, so nothing supports this line of enquiry specifically. The heading describes where the compound is discussed in this category, not what has been shown about it.
No paper is cited on this page for Semax Spray, so nothing supports this line of enquiry specifically. The heading describes where the compound is discussed in this category, not what has been shown about it.
No primary literature is cited on this page for Semax Spray. Where a compound has little or no indexed research behind it, saying so is more useful than presenting a thin record as a full one.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Semax Spray, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Semax Spray is also referred to as semax.
Semax Spray is commonly described online in connection with sharper focus, better memory and improved mood. In the research literature the same compound is filed under neuropeptide signaling pathway models, ACTH fragment research frameworks and central signaling system investigations.
No primary literature is cited on this page for Semax Spray, because none suitable for citation was identified. That is the finding, not an omission: where a compound has no indexed published research behind it, no claim about what it does in any system is supported — including the framing above. It is supplied strictly as a research material for laboratory use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Verification for Semax Spray is per lot, not per product. The current 10mg lot SMAX-CA-26G-10 returned 99.053% purity, 10.69 mg measured, 106.9% of the labelled 10 mg, assayed by Janoshik. Those figures are the laboratory's, published in full rather than reduced to a badge.
The lot code printed on the vial matches the code on the certificate for Semax Spray. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy Semax Spray in Canada through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
Semax Spray ships as a prepared solution rather than as lyophilized powder, so it is already past the point at which a powder would be reconstituted. That shortens handling but tightens storage: a compound in solution is less stable than the same compound dry, and refrigeration from arrival onward is the relevant control.
The stability window for a solution is shorter than the shelf life of a sealed lyophilized vial of the same compound. Records for laboratory work in this format should note the date the unit was opened, not only the date it was received.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains 12mg of Semax in a 10 mL spray presentation delivering 100 mcg per spray. Independent third-party testing verifies purity, identity, and batch specifications.
The product is supplied in a ready-to-use research presentation. No additional laboratory materials are included.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Related
Eppix Flash Sale −30%Peptides
Triple GIP / GLP-1 / Glucagon Agonist · 10, 20, 40 & 120 mg Retatrutide is a synthetic peptide developed for controlled laboratory research involving multi-receptor signaling systems. It is structurally designed to interact with GLP-1, GIP, and glucagon receptor pathways within experimental environments.
RETA-CA-26F-1099.637%
11.76 mg / 10 mg
$41.96$59.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
Dual GIP / GLP-1 Agonist · 10, 30 & 65 mg Tirzepatide is a synthetic peptide developed for controlled laboratory research involving dual incretin receptor signaling systems. It is structurally designed to interact with GLP-1 and GIP receptor pathways within experimental environments.
TIRZ-CA-26G-1099.634%
11.42 mg / 10 mg
$24.46$34.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
GLP-1 Receptor Agonist · 10 mg Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose-dependent signaling. It is developed for controlled laboratory investigation within regulated experimental environments.
10 mgSEMA-CA-26F-1099.504%
11.27 mg / 10 mg
$38.46$54.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
Selective Amylin Agonist (LY3841136) · 10 mg This product is supplied as eloralintide (LY3841136), a long-acting, selective amylin receptor agonist studied in research on metabolic and body-weight regulation.
10 mgELOR-CA-26G-1099.810%
12.42 mg / 10 mg
$101.46$144.95CAD
Flash sale ends in
